Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Change in Acquisitions & Divestments (2016 - 2021)

Mimedx's Change in Acquisitions & Divestments history spans 6 years, with the latest figure at $30000.0 for Q3 2021.

  • For Q3 2021, Change in Acquisitions & Divestments changed N/A year-over-year to $30000.0; the TTM value through Jun 2022 reached $30000.0, down 33.33%, while the annual FY2021 figure was $75000.0, N/A changed from the prior year.
  • Change in Acquisitions & Divestments for Q3 2021 was $30000.0 at Mimedx, roughly flat from $30000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $2.3 million in Q3 2019 and bottomed at $15000.0 in Q1 2021.
  • The 3-year median for Change in Acquisitions & Divestments is $209500.0 (2019), against an average of $595833.3.